244 related articles for article (PubMed ID: 30615569)
1. Preferred Product Attributes of Potential Multipurpose Prevention Technologies for Unintended Pregnancy and Sexually Transmitted Infections or HIV Among U.S. Women.
Hynes JS; Sheth AN; Lathrop E; Sales JM; Haddad LB
J Womens Health (Larchmt); 2019 May; 28(5):665-672. PubMed ID: 30615569
[No Abstract] [Full Text] [Related]
2. Interest in multipurpose prevention technologies to prevent HIV/STIs and unintended pregnancy among young women in the United States.
Hynes JS; Sales JM; Sheth AN; Lathrop E; Haddad LB
Contraception; 2018 Mar; 97(3):277-284. PubMed ID: 29055782
[TBL] [Abstract][Full Text] [Related]
3. Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention.
Krovi SA; Johnson LM; Luecke E; Achilles SL; van der Straten A
Adv Drug Deliv Rev; 2021 Sep; 176():113849. PubMed ID: 34186143
[TBL] [Abstract][Full Text] [Related]
4. Preferences, educational messaging, and demand creation channels for multipurpose-prevention technologies (MPTs) among women in South Africa.
Mataboge P; Mthimkhulu N; Kutywayo A; Martin CE; Mazibuko M; Kwatsha K; Makalela N; Briedenhann E; Butler V; Bothma R; Mullick S
BMC Public Health; 2023 Oct; 23(1):2090. PubMed ID: 37880628
[TBL] [Abstract][Full Text] [Related]
5. Women Want Choices: Opinions from the Share.Learn.Shape Global Internet Survey About Multipurpose Prevention Technology (MPT) Products in Development.
Friedland BA; Plagianos M; Savel C; Kallianes V; Martinez C; Begg L; Guthrie KM; Venkatasetty D; Pickett J; Haddad LB
AIDS Behav; 2023 Jul; 27(7):2190-2204. PubMed ID: 36881183
[TBL] [Abstract][Full Text] [Related]
6. Beyond HIV microbicides: multipurpose prevention technology products.
Malcolm RK; Boyd P; McCoy CF; Murphy DJ
BJOG; 2014 Oct; 121 Suppl 5():62-9. PubMed ID: 25335842
[TBL] [Abstract][Full Text] [Related]
7. Making the Case for Joint Decision-Making in Future Multipurpose Prevention Technology (MPT) Choice: Qualitative Findings on MPT Attribute Preferences from the CUPID Study (MTN-045).
Bhushan NL; Musara P; Hartmann M; Stoner MCD; Shah SR; Nabukeera J; Rukundo I; Mutero P; Lewis MA; Piper J; Shapley-Quinn MK; Etima J; Minnis AM
J Int AIDS Soc; 2022 Oct; 25(10):e26024. PubMed ID: 36254362
[TBL] [Abstract][Full Text] [Related]
8. Multipurpose prevention technologies for sexual and reproductive health: mapping global needs for introduction of new preventive products.
Schelar E; Polis CB; Essam T; Looker KJ; Bruni L; Chrisman CJ; Manning J
Contraception; 2016 Jan; 93(1):32-43. PubMed ID: 26385588
[TBL] [Abstract][Full Text] [Related]
9. A strategic action framework for multipurpose prevention technologies combining contraceptive hormones and antiretroviral drugs to prevent pregnancy and HIV.
Young Holt B; Dellplain L; Creinin MD; Peine KJ; Romano J; Hemmerling A
Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):326-334. PubMed ID: 30247084
[TBL] [Abstract][Full Text] [Related]
10. The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention.
van der Straten A; Agot K; Ahmed K; Weinrib R; Browne EN; Manenzhe K; Owino F; Schwartz J; Minnis A;
J Int AIDS Soc; 2018 Mar; 21(3):e25094. PubMed ID: 29600595
[TBL] [Abstract][Full Text] [Related]
11. Prioritizing multipurpose prevention technology development and investments using a target product profile.
Romano J; Manning J; Hemmerling A; McGrory E; Holt BY
Antiviral Res; 2013 Dec; 100 Suppl():S32-8. PubMed ID: 24188707
[TBL] [Abstract][Full Text] [Related]
12. Emerging Technologies to Prevent Pregnancy and Sexually Transmitted Infections in Women.
Seidman D; Hemmerling A; Smith-McCune K
Semin Reprod Med; 2016 May; 34(3):159-67. PubMed ID: 26956691
[TBL] [Abstract][Full Text] [Related]
13. Multipurpose prevention technologies: products in development.
Friend DR; Clark JT; Kiser PF; Clark MR
Antiviral Res; 2013 Dec; 100 Suppl():S39-47. PubMed ID: 24188708
[TBL] [Abstract][Full Text] [Related]
14. Multipurpose prevention technologies for reproductive and sexual health.
Stone A
Reprod Health Matters; 2014 Nov; 22(44):213-7. PubMed ID: 25555778
[TBL] [Abstract][Full Text] [Related]
15. An update on multipurpose prevention technologies for the prevention of HIV transmission and pregnancy.
Friend DR
Expert Opin Drug Deliv; 2016; 13(4):533-45. PubMed ID: 26742698
[TBL] [Abstract][Full Text] [Related]
16. Racial/ethnic differences in contraceptive preferences, beliefs, and self-efficacy among women veterans.
Callegari LS; Zhao X; Schwarz EB; Rosenfeld E; Mor MK; Borrero S
Am J Obstet Gynecol; 2017 May; 216(5):504.e1-504.e10. PubMed ID: 28063910
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous prevention of unintended pregnancy and STIs: a challenging compromise.
ESHRI Capri Workshop Group
Hum Reprod Update; 2014; 20(6):952-63. PubMed ID: 24935861
[TBL] [Abstract][Full Text] [Related]
18. Young Women's Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa.
Minnis AM; Roberts ST; Agot K; Weinrib R; Ahmed K; Manenzhe K; Owino F; van der Straten A;
AIDS Behav; 2018 Aug; 22(8):2662-2673. PubMed ID: 29560570
[TBL] [Abstract][Full Text] [Related]
19. Vaginal multipurpose prevention technologies: promising approaches for enhancing women's sexual and reproductive health.
Fernandes T; Baxi K; Sawarkar S; Sarmento B; das Neves J
Expert Opin Drug Deliv; 2020 Mar; 17(3):379-393. PubMed ID: 32036727
[No Abstract] [Full Text] [Related]
20. Young Women's Stated Preferences for Biomedical HIV Prevention: Results of a Discrete Choice Experiment in Kenya and South Africa.
Minnis AM; Browne EN; Boeri M; Agot K; van der Straten A; Ahmed K; Weinrib R; Mansfield C
J Acquir Immune Defic Syndr; 2019 Apr; 80(4):394-403. PubMed ID: 30633040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
